Completed PHASE3 INTERVENTIONAL 2-arm NCT00922480

Clinical Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Hypertension Patients

A Randomized, Double-blind, Losartan-controlled, Parallel Group Comparison Dose Titration Clinical Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan 60mg~120mg in Patients With Mild to Moderate Essential Hypertension

Sponsor: Ajou University

Conditions Hypertension

Interventions Fimasartan Losartan (Control)

Updated 9 times since 2017 Last updated: Mar 15, 2018 Started: Dec 31, 2008 Primary completion: Jul 31, 2009 Completion: Sep 30, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Hypertension, this trial is completed. The trial is conducted by Ajou University and has accumulated 9 data snapshots since 2008. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Sep 2020 — Jan 2021 [monthly]

Completed PHASE3
Jun 2018 — Sep 2020 [monthly]

Completed PHASE3

▶ Show 4 earlier versions

May 2018 — Jun 2018 [monthly]

Completed PHASE3
Mar 2018 — May 2018 [monthly]

Completed PHASE3
Jun 2017 — Mar 2018 [monthly]

Completed PHASE3
Jan 2017 — Jun 2017 [monthly]

Completed PHASE3

First recorded

Dec 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ajou University
Asan Medical Center
Boryung Pharmaceutical Co., Ltd
Cheil General Hospital and Women's Healthcare Center
Chonbuk National University Hospital
Chungbuk National University Hospital
Chungnam National University
Dongguk University International Hospital
Hanyang University
Inha University Hospital
Kangbuk Samsung Hospital
Keimyung University
Konkuk University Medical Center
Konyang University Hospital
Korea University
Korea University Guro Hospital
Samsung Medical Center
Seoul National University Bundang Hospital
Seoul National University Hospital
Severance Hospital
The Catholic University of Korea
Wonju Severance Christian Hospital
Yeungnam University Hospital
Yonsei University

Data source: Boryung Pharmaceutical Co., Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.